Piper Sandler Downgrades Xeris Biopharma Holdings (LSE:0A8E)
ソース:
NASDAQ Stocks
/
12 11 2024 02:29:14 America/New_York
Fintel reports that on November 11, 2024, Piper Sandler downgraded their outlook for Xeris Biopharma Holdings (LSE:0A8E) from Overweight to Neutral. https://www.nasdaq.com/articles/piper-sandler-downgrades-xeris-biopharma-holdings-lse-0a8e
シェアする